This is what it looks like to connect industrial capacity, logistics, resilience, workforce development and national security in one strategic frame. Finally, on pharmaceuticals, President Trump signed an executive order to fill the strategic Active Pharmaceutical Ingredients reserve so that America is never again caught flat footed when access to critical drug components is at risk. Last month, the White House also highlighted further action to impose tariffs on patented pharmaceutical products, while noting parallel section 232 Investigations involving personal protective equipment, medical consumable devices and robotics. (11:02–11:18)
CLAIM
Asserts that an executive order was signed to fill the strategic reserve of Active Pharmaceutical Ingredients.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
